Riskpilot← Back to searchSign inGet full accessHELSEGYM1 AS
ASActiveOrg 982980321Leklemsåsen 80, 7655 VerdalOther human health activities n.e.c. · NACE 8699Est. 20011 employeeswww.helsegym1.no
Revenue 2024
NOK 1,6M
+1% vs 2023
EBITDA margin
0.7%
+120% vs 2023
Equity ratio
65.3%
Financial strength
Net profit 2024
NOK -7K
+90% vs 2023
| Revenue | NOK 1,6M | +1% |
| EBITDA | NOK 12K | +120% |
| Net profit | NOK -7K | +90% |
| Total assets | NOK 422K | -18% |
| Equity | NOK 276K | -2% |
| Employees | 1 | — |
Legal name
HELSEGYM1 AS
Org number
982980321
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
12. februar 2001
Share capital
NOK 402 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder alene.
Company purpose
Helsefremmende og forebyggende arbeid, med vekt på gruppe og indivdibasert trening i tillegg til undervisning, utredning og behandling. Har også åpning for deltakelse i andre virksomheter ved akjsetegning eller på annne måte.
Address
Leklemsåsen 80, 7655 Verdal
Website
www.helsegym1.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 026 | 1 603 | 1 625 | 1 617 | 1 634 |
| Staff expenses | −504 | −789 | −859 | −881 | −879 |
| EBITDA | −123 | 111 | 47 | −60 | 12 |
| Depreciation & amort. | −12 | −17 | −22 | −20 | −20 |
| EBIT | −135 | 93 | 24 | −81 | −9 |
| Net financials | −5 | −7 | −8 | −6 | −0 |
| Profit before tax | −141 | 86 | 17 | −87 | −9 |
| Tax | −31 | 19 | 4 | −19 | −2 |
| Net profit | −110 | 67 | 13 | −68 | −7 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 425 | 592 | 576 | 513 | 422 |
| Equity | 270 | 337 | 350 | 283 | 276 |
| Long-term debt | 0 | 106 | 84 | 62 | 0 |
| Short-term debt | 155 | 149 | 142 | 168 | 146 |
| Total debt | 155 | 255 | 226 | 230 | 146 |
EBITDA margin
0.7%
This company
15.8%
Market median
-96% vs market
20202024
Equity ratio
65.3%
This company
38.2%
Market median
+71% vs market
20202024
Return on equity
-2.5%
This company
18.4%
Market median
-114% vs market
20202024
Net profit margin
-0.4%
This company
8.1%
Market median
-105% vs market
20202024
Asset turnover
3.87×
This company
1.12×
Market median
+246% vs market
20202024
Debt / equity
0.53×
This company
0.62×
Market median
+15% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JT Chief Executive Officer | Chief Executive Officer | 2006 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2013 | |
| Board of Directors | 2013 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 7.46% | 7.46% | 2024 | |
| Individual | 6.47% | 6.47% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of HELSEGYM1 AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jarle Taranger Nesbø | Chief Executive Officer | 0 companies |
| Bernt Olav Karlgård | Chairman | 0 companies |
| Svein Erik Melvold | Board of Directors | 0 companies |